New Hope for Lyme Disease Prevention

Blacklegged_tick

Lyme disease is caused by bacteria (Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii) that are delivered by a bite from an infected tick (Figure 1). The Centers for Disease Control (1) recommend a preventative (prophylactic) single dose of the antibiotic doxycycline for adults bitten by a mosquito with a high probability of carrying the Lyme-causing … Read more

The Power of Proteomics in Medicine

mass_spectrometry_proteomics

  Although genomic (DNA) and transcriptomic (messenger RNA) data are easier to collect and analyze, these are only two of the relevant types of “omic” data that are important for understanding disease and the response to treatments. Proteomic, metabolomic, and lipidomic data are also contain information that can be used diagnostically, prognostically, in developing treatment … Read more

Single-Cell Proteomics Shines Light on the Complexity of Immune Cells in Solid Tumors

Phenograph_clustering_example

A Proteomic Approach to the Tumor Microenvironment An outstanding issue in treating solid cancers is understanding the complexity of this pathological tissue. Solid tumors are comprised not only of the cancer cells, but they also contain immune cells, cells that form blood vessels and lymphatic vessels, fibroblasts, and the stem cells that form the fibroblasts … Read more

Proteomics Improves Antigen Prediction

Vaccine_development

How will we benefit from being able to accurately predict the peptide antigens that the immune system can recognize? Vaccine development would be a major beneficiary of such knowledge (Figure 1). We could produce more effective and safer vaccines. We could develop vaccines for pathogens for which no vaccine is currently available. We could ensure … Read more

Therapeutic Applications for Inhibitors and Activators of RANKL/RANK Signaling

Bone_Marrow_Extraction

Target tissue type, as well as a patient’s gender, nutritional, and reproductive status, must be considered to manipulate signaling through the RANKL/RANK pathway for therapeutic benefit. In some contexts, activating this pathway can be beneficial and in others inhibiting this pathway is beneficial. RANKL is the ligand, RANK [receptor activator of nuclear factor kappa-B (NF-κB)] … Read more